Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 2,670,447 |
|
|||||
| News | - | ||||||
| Day High | 103.795 | Low High |
|||||
| Day Low | 100.45 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.99 | -0.97% | 101.01 | 19:45:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 102.37 | 100.45 | 103.795 | 101.41 | 102.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 41,080 | 2,670,447 | $ 101.98 | $ 272,324,975 | - | 62.55 - 144.43 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:42:10 | 15 | $ 101.12 | USD |
Moderna (MRNA) Options Flow Summary
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 38.75B | 382.07M | - | 6.85B | -4.71B | -12.34 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Moderna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 105.57 | 107.88 | 99.90 | 103.74 | 2,092,039 | -4.56 | -4.32% |
| 1 Month | 104.11 | 115.89 | 97.00 | 106.41 | 3,258,887 | -3.10 | -2.98% |
| 3 Months | 103.50 | 115.89 | 84.06 | 100.39 | 3,817,650 | -2.49 | -2.41% |
| 6 Months | 85.81 | 115.97 | 62.55 | 92.83 | 4,498,971 | 15.20 | 17.71% |
| 1 Year | 141.54 | 144.43 | 62.55 | 103.06 | 4,049,487 | -40.53 | -28.64% |
| 3 Years | 166.79 | 497.17 | 62.55 | 219.41 | 7,050,018 | -65.78 | -39.44% |
| 5 Years | 23.73 | 497.17 | 11.54 | 147.54 | 8,833,894 | 77.28 | 325.66% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
